Actively Recruiting
Study of Retinal Imaging Using Optical Coherence Tomography Angiography in Adults With or Without Retinal Vascular Disease
Led by Johns Hopkins University · Updated on 2026-06-17
1050
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a prospective, longitudinal study to analyze clinical and imaging findings from both healthy individuals and those with retinal vascular diseases. The aim is to better define imaging criteria that indicate changes in disease stages, including progression in early disease or regression with standard treatments. The study includes participants with conditions such as diabetic retinopathy, hypertension, retinal vein or arterial occlusion, and macular degeneration. Participants will undergo several non-invasive, minimal risk, FDA-approved imaging procedures including Swept-Source OCT Angiography, Spectral-Domain OCT Angiography, Fundus Imaging, and Axial Length Measurement. The study groups include healthy controls and various disease groups defined by diabetes and hypertension status. Some subjects may also have retinal vascular reactivity assessments. Imaging data collected through standard care methods will be reviewed retrospectively and prospectively. Throughout the study, participants will have their diagnostic imaging findings correlated with clinical disease stage and visual acuity. Researchers will monitor changes over up to five years to assess disease progression or regression. The study involves regular imaging assessments and clinical evaluations to collect data, with a focus on safe, non-invasive techniques. Total participation time can extend to the full study duration ending in 2027.
CONDITIONS
Brief Title
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
Research Team
A
Amir H Kashani, MD, PhD
A
Ana C Martinez, MPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here